Abstract
Genetic mutations and defects in mitochondrial DNA (mtDNA) are associated with certain types of mitochondrial dysfunctions, ultimately resulting in the emergence of a variety of human diseases. To achieve an effective mitochondrial gene therapy, it will be necessary to deliver therapeutic agents to the innermost mitochondrial space (the mitochondrial matrix), which contains the mtDNA pool. We recently developed a MITO-Porter, a liposome-based nanocarrier that delivers cargo to mitochondria via a membrane-fusion mechanism. In this chapter, we discuss the methodology used to deliver bioactive molecules to the mitochondrial matrix using a Dual Function (DF)-MITO-Porter, a liposome-based nanocarrier that delivers it cargo by means of a stepwise process, and an evaluation of mtDNA levels and mitochondrial activities in living cells. We also discuss mitochondrial gene silencing by the mitochondrial delivery of antisense RNA oligonucleotide (ASO) targeting mtDNA-encoded mRNA using the MITO-Porter system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Chen H, Chan DC (2009) Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum Mol Genet 18(R2):R169–R176
Kyriakouli DS, Boesch P, Taylor RW, Lightowlers RN (2008) Progress and prospects: gene therapy for mitochondrial DNA disease. Gene Ther 15(14):1017–1023
Schapira AH (2006) Mitochondrial disease. Lancet 368(9529):70–82
Yamada Y, Akita H, Kamiya H, Kogure K, Yamamoto T, Shinohara Y, Yamashita K, Kobayashi H, Kikuchi H, Harashima H (2008) MITO-porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim Biophys Acta 1778(2):423–432
Yamada Y, Harashima H (2008) Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv Drug Deliv Rev 60(13-14):1439–1462
Kogure K, Akita H, Yamada Y, Harashima H (2008) Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. Adv Drug Deliv Rev 60(4-5):559–571
Khalil IA, Kogure K, Futaki S, Harashima H (2006) High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J Biol Chem 281(6):3544–3551
Del Gaizo V, Payne RM (2003) A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. Mol Ther 7(6):720–730
Yamada Y, Akita H, Harashima H (2012) Multifunctional envelope-type nano device (MEND) for organelle targeting via a stepwise membrane fusion process. Methods Enzymol 509:301–326
Yasuzaki Y, Yamada Y, Harashima H (2010) Mitochondrial matrix delivery using MITO-porter, a liposome-based carrier that specifies fusion with mitochondrial membranes. Biochem Biophys Res Commun 397(2):181–186
Yamada Y, Daikuhara S, Tamura A, Nishida K, Yui N, Harashima H (2019) Enhanced autophagy induction via the mitochondrial delivery of methylated beta-cyclodextrin-threaded polyrotaxanes using a MITO-porter. Chem Commun (Camb) 55(50):7203–7206
Satrialdi, Munechika R, Biju V, Takano Y, Harashima H, Yamada Y (2020) The optimization of cancer photodynamic therapy by utilization of a pi-extended porphyrin-type photosensitizer in combination with MITO-porter. Chem Commun (Camb) 56(7):1145–1148
Hibino M, Yamada Y, Fujishita N, Sato Y, Maeki M, Tokeshi M, Harashima H (2019) The use of a microfluidic device to encapsulate a poorly water-soluble drug CoQ10 in lipid nanoparticles and an attempt to regulate intracellular trafficking to reach mitochondria. J Pharm Sci 108(8):2668–2676
Yamada Y, Takano Y, Satrialdi, Abe J, Hibino M, Harashima H (2020) Therapeutic strategies for regulating mitochondrial oxidative stress. Biomol Ther 10(1):83
Yamada Y, Fujishita N, Harashima H (2020) A nanocarrier for the mitochondrial delivery of nucleic acids to cardiomyocytes. Nucleosides Nucleotides Nucleic Acids 39:141–155
Ishikawa T, Somiya K, Munechika R, Harashima H, Yamada Y (2018) Mitochondrial transgene expression via an artificial mitochondrial DNA vector in cells from a patient with a mitochondrial disease. J Control Release 274:109–117
Kawamura E, Maruyama M, Abe J, Sudo A, Takeda A, Takada S, Yokota T, Kinugawa S, Harashima H, Yamada Y (2020) Validation of gene therapy for mutant mitochondria by delivering mitochondrial RNA using a MITO-porter, a liposome-based nano device. Mol Ther Nucl Acids 20:687–698
Yamada Y, Furukawa R, Yasuzaki Y, Harashima H (2011) Dual function MITO-porter, a Nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery. Mol Ther 19(8):1449–1456
Yamada Y, Harashima H (2012) Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-porter. Biomaterials 33(5):1589–1595
Yamada Y, Kawamura E, Harashima H (2012) Mitochondrial-targeted DNA delivery using a DF-MITO-porter, an innovative nano carrier with cytoplasmic and mitochondrial fusogenic envelopes. J Nanopart Res 14(8):1013–1027
Furukawa R, Yamada Y, Kawamura E, Harashima H (2015) Mitochondrial delivery of antisense RNA by MITO-porter results in mitochondrial RNA knockdown, and has a functional impact on mitochondria. Biomaterials 57:107–115
Kawamura E, Hibino M, Harashima H, Yamada Y (2019) Targeted mitochondrial delivery of antisense RNA-containing nanoparticles by a MITO-porter for safe and efficient mitochondrial gene silencing. Mitochondrion 49:178–188
Yamada Y, Fukuda Y, Sasaki D, Maruyama M, Harashima H (2020) Development of a nanoparticle that releases nucleic acids in response to a mitochondrial environment. Mitochondrion 52:67–74
Futaki S, Ohashi W, Suzuki T, Niwa M, Tanaka S, Ueda K, Harashima H, Sugiura Y (2001) Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem 12(6):1005–1011
Kakudo T, Chaki S, Futaki S, Nakase I, Akaji K, Kawakami T, Maruyama K, Kamiya H, Harashima H (2004) Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 43(19):5618–5628
Kusumoto K, Akita H, Ishitsuka T, Matsumoto Y, Nomoto T, Furukawa R, El-Sayed A, Hatakeyama H, Kajimoto K, Yamada Y, Kataoka K, Harashima H (2013) Lipid envelope-type nanoparticle incorporating a multifunctional peptide for systemic siRNA delivery to the pulmonary endothelium. ACS Nano 7(9):7534–7541
Akita H, Kudo A, Minoura A, Yamaguti M, Khalil IA, Moriguchi R, Masuda T, Danev R, Nagayama K, Kogure K, Harashima H (2009) Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process. Biomaterials 30(15):2940–2949
Lee RJ, Huang L (1996) Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem 271(14):8481–8487
Yamada Y, Tabata M, Yasuzaki Y, Nomura M, Shibata A, Ibayashi Y, Taniguchi Y, Sasaki S, Harashima H (2014) A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line. Biomaterials 35(24):6430–6438
Kogure K, Moriguchi R, Sasaki K, Ueno M, Futaki S, Harashima H (2004) Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J Control Release 98(2):317–323
El-Sayed A, Khalil IA, Kogure K, Futaki S, Harashima H (2008) Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape. J Biol Chem 283(34):23450–23461
Acknowledgements
This work was supported, in part by, the Grant-in-Aid for Young Scientists (A) and Grant-in-Aid for Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japanese Government (MEXT), and the A-STEP feasibility study program in Japan Science and Technology Agency (JST). We also wish to thank Dr. Milton Feather for his helpful advice in writing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Yamada, Y., Harashima, H. (2021). Targeting the Mitochondrial Genome Via a MITO-Porter : Evaluation of mtDNA and mtRNA Levels and Mitochondrial Function . In: Weissig, V., Edeas, M. (eds) Mitochondrial Medicine . Methods in Molecular Biology, vol 2275. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1262-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1262-0_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1261-3
Online ISBN: 978-1-0716-1262-0
eBook Packages: Springer Protocols